Skip to main content
Erschienen in: International Ophthalmology 3/2018

19.04.2017 | Original Paper

Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy

verfasst von: T. Barth, F. Zeman, H. Helbig, M.-A. Gamulescu

Erschienen in: International Ophthalmology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess the outcome of patients with choroidal neovascularization (CNV) secondary to punctate inner choroidopathy (PIC) receiving intravitreal anti-VEGF (vascular endothelial growth factor) injections.

Methods

Sixteen eyes of 16 patients diagnosed with CNV secondary to PIC were retrospectively assessed.

Results

Eleven women and five men with a mean age of 35 years (SD 11, range 16–56 years) received intravitreal anti-VEGF for PIC-related CNV. On average, 3.5 injections (SD 2.7, range 1–9) were given per eye. Thirteen eyes were treated with bevacizumab, two eyes with ranibizumab and one eye received both substances. The mean follow-up was 15 months (SD 11, range 6–40 months). BCVA improved in eight eyes (mean Δ +2.8 lines), remained stable in four eyes and decreased in four eyes (mean Δ −4.3 lines).

Conclusions

CNV development is a frequent complication of PIC. Intravitreal anti-VEGF therapy seems to be safe and effective for PIC-related CNV.
Literatur
2.
Zurück zum Zitat Zhang H, Liu Z, Sun P, Gu F (2012) Intravitreal bevacizumab as primary treatment of choroidal neovascularization secondary to punctate inner choroidopathy: results of a 1-year prospective trial. Retina 32(6):1106–1113CrossRefPubMed Zhang H, Liu Z, Sun P, Gu F (2012) Intravitreal bevacizumab as primary treatment of choroidal neovascularization secondary to punctate inner choroidopathy: results of a 1-year prospective trial. Retina 32(6):1106–1113CrossRefPubMed
3.
Zurück zum Zitat Campos J, Campos A, Mendes S, Neves A, Beselga D, Castro Sousa JP (2014) Punctate inner choroidopathy: a systematic review. Med Hypothesis Discov Innov Ophthalmol 3(3):76–82PubMedPubMedCentral Campos J, Campos A, Mendes S, Neves A, Beselga D, Castro Sousa JP (2014) Punctate inner choroidopathy: a systematic review. Med Hypothesis Discov Innov Ophthalmol 3(3):76–82PubMedPubMedCentral
4.
Zurück zum Zitat Watzke RC, Packer AJ, Folk JC, Benson WE, Borgess D, Ober RR (1984) Punctate inner choroidopathy. Am J Ophthalmol 98(5):572–584CrossRefPubMed Watzke RC, Packer AJ, Folk JC, Benson WE, Borgess D, Ober RR (1984) Punctate inner choroidopathy. Am J Ophthalmol 98(5):572–584CrossRefPubMed
5.
Zurück zum Zitat Leung TG, Moradi A, Liu D, Nguyen QD, Dunn JP, Burkholder B, Butler NJ, Ostheimer T, Thorne JE (2014) Clinical features and incidence rate of ocular complications in punctate inner choroidopathy. Retina 34(8):1666–1674CrossRefPubMed Leung TG, Moradi A, Liu D, Nguyen QD, Dunn JP, Burkholder B, Butler NJ, Ostheimer T, Thorne JE (2014) Clinical features and incidence rate of ocular complications in punctate inner choroidopathy. Retina 34(8):1666–1674CrossRefPubMed
6.
Zurück zum Zitat Diaz RI, Sigler EJ, Rafieetary MR, Calzada JI (2015) Ocular histoplasmosis syndrome. Surv Ophthalmol 60:279–295CrossRefPubMed Diaz RI, Sigler EJ, Rafieetary MR, Calzada JI (2015) Ocular histoplasmosis syndrome. Surv Ophthalmol 60:279–295CrossRefPubMed
7.
Zurück zum Zitat Amaro MH, Muccioli C, Abreu MT (2007) Ocular histoplasmosis-like syndrome: a report from a nonendemic area. Arq Bras Oftalmol 70(4):577–580CrossRefPubMed Amaro MH, Muccioli C, Abreu MT (2007) Ocular histoplasmosis-like syndrome: a report from a nonendemic area. Arq Bras Oftalmol 70(4):577–580CrossRefPubMed
8.
Zurück zum Zitat Watzke RC, Klein ML, Wener MH (1998) Histoplasmosis-like choroiditis in a nonendemic area: the northwest United States. Retina 18(3):204–212CrossRefPubMed Watzke RC, Klein ML, Wener MH (1998) Histoplasmosis-like choroiditis in a nonendemic area: the northwest United States. Retina 18(3):204–212CrossRefPubMed
9.
Zurück zum Zitat Essex RW, Wong J, Fraser-Bell S, Sandbach J, Tufail A, Bird AC, Dowler J (2010) Punctate inner choroidopathy: clinical features and outcomes. Arch Ophthalmol 128(8):982–987CrossRefPubMed Essex RW, Wong J, Fraser-Bell S, Sandbach J, Tufail A, Bird AC, Dowler J (2010) Punctate inner choroidopathy: clinical features and outcomes. Arch Ophthalmol 128(8):982–987CrossRefPubMed
10.
Zurück zum Zitat Chatterjee S, Gibson JM (2003) Photodynamic therapy: a treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy. Br J Ophthalmol 87(7):925–927CrossRefPubMedPubMedCentral Chatterjee S, Gibson JM (2003) Photodynamic therapy: a treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy. Br J Ophthalmol 87(7):925–927CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Brueggeman RM, Noffke AS, Jampol LM (2002) Resolution of punctate inner choroidopathy lesions with oral prednisone therapy. Arch Ophthalmol 120(7):996CrossRefPubMed Brueggeman RM, Noffke AS, Jampol LM (2002) Resolution of punctate inner choroidopathy lesions with oral prednisone therapy. Arch Ophthalmol 120(7):996CrossRefPubMed
12.
Zurück zum Zitat Gerstenblith AT, Thorne JE, Sobrin L, Do DV, Shah SM, Foster CS, Jabs DA, Nguyen QD (2007) Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology 114(6):1201–1204CrossRefPubMed Gerstenblith AT, Thorne JE, Sobrin L, Do DV, Shah SM, Foster CS, Jabs DA, Nguyen QD (2007) Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology 114(6):1201–1204CrossRefPubMed
13.
Zurück zum Zitat Patel KH, Birnbaum AD, Tessler HH, Goldstein DA (2011) Presentation and outcome of patients with punctate inner choroidopathy at a tertiary referral center. Retina 31(7):1387–1391CrossRefPubMed Patel KH, Birnbaum AD, Tessler HH, Goldstein DA (2011) Presentation and outcome of patients with punctate inner choroidopathy at a tertiary referral center. Retina 31(7):1387–1391CrossRefPubMed
14.
Zurück zum Zitat Olsen TW, Capone A, Sternberg P, Grossniklaus HE, Martin DF, Aaberg TM (1996) Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings. Ophthalmology 103(12):2061–2069CrossRefPubMed Olsen TW, Capone A, Sternberg P, Grossniklaus HE, Martin DF, Aaberg TM (1996) Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings. Ophthalmology 103(12):2061–2069CrossRefPubMed
15.
Zurück zum Zitat Brown J, Folk JC, Reddy CV, Kimura AE (1996) Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology 103(7):1100–1105CrossRefPubMed Brown J, Folk JC, Reddy CV, Kimura AE (1996) Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology 103(7):1100–1105CrossRefPubMed
16.
Zurück zum Zitat Wachtlin J, Heimann H, Behme T, Foerster MH (2003) Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases. Graefe’s Arch Clin Exp Ophthalmol 241:899–906CrossRef Wachtlin J, Heimann H, Behme T, Foerster MH (2003) Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases. Graefe’s Arch Clin Exp Ophthalmol 241:899–906CrossRef
17.
Zurück zum Zitat Carneiro AM, Silva RM, Veludo MJ, Barbosa A, Ruiz-Moreno JM, Falcao MS, Brandao EM, Falcao-Reis FM (2011) Ranibizumab treatment for choroidal neovascularization from causes other than age-related macular degeneration and pathological myopia. Ophthalmologica 225(2):81–88CrossRefPubMed Carneiro AM, Silva RM, Veludo MJ, Barbosa A, Ruiz-Moreno JM, Falcao MS, Brandao EM, Falcao-Reis FM (2011) Ranibizumab treatment for choroidal neovascularization from causes other than age-related macular degeneration and pathological myopia. Ophthalmologica 225(2):81–88CrossRefPubMed
18.
19.
Zurück zum Zitat Schadlu R, Blinder KJ, Shah GK, Holekamp NM, Thomas MA, Grand MG, Engelbrecht NE, Apte RS, Joseph DP, Prasad AG, Smith BT, Sheybani A (2008) Intravitreal bevacizumab for choroidal neovascularization in ocular histoplasmosis. Am J Ophthalmol 145(5):875–878CrossRefPubMed Schadlu R, Blinder KJ, Shah GK, Holekamp NM, Thomas MA, Grand MG, Engelbrecht NE, Apte RS, Joseph DP, Prasad AG, Smith BT, Sheybani A (2008) Intravitreal bevacizumab for choroidal neovascularization in ocular histoplasmosis. Am J Ophthalmol 145(5):875–878CrossRefPubMed
20.
Zurück zum Zitat Campos J, Campos A, Beselga D, Mendes S, Neves A, Sousa JP (2013) Punctate inner choroidopathy: a clinical case report. Case Rep Ophthalmol 4(3):155–159CrossRefPubMedPubMedCentral Campos J, Campos A, Beselga D, Mendes S, Neves A, Sousa JP (2013) Punctate inner choroidopathy: a clinical case report. Case Rep Ophthalmol 4(3):155–159CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Hohberger B, Rudolph M, Bergua A (2015) Choroidal neovascularization associated with punctate inner choroidopathy: combination of intravitreal anti-VEGF and systemic immunosuppressive therapy. Case Rep Ophthalmol 6(3):385–389CrossRefPubMedPubMedCentral Hohberger B, Rudolph M, Bergua A (2015) Choroidal neovascularization associated with punctate inner choroidopathy: combination of intravitreal anti-VEGF and systemic immunosuppressive therapy. Case Rep Ophthalmol 6(3):385–389CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Mangat SS, Ramasamy B, Prasad S, Walters G, Mohammed M, Mckibbin M (2011) Resolution of choroidal neovascularization secondary to punctate inner choroidopathy (PIC) with intravitreal anti-VEGF agents: a case series. Semin Ophthalmol 26(1):1–3CrossRefPubMed Mangat SS, Ramasamy B, Prasad S, Walters G, Mohammed M, Mckibbin M (2011) Resolution of choroidal neovascularization secondary to punctate inner choroidopathy (PIC) with intravitreal anti-VEGF agents: a case series. Semin Ophthalmol 26(1):1–3CrossRefPubMed
23.
Zurück zum Zitat Vossmerbaeumer U, Spandau UHM, Baltz SV, Wickenhaeuser A, Jonas JB (2008) Intravitreal bevacizumab for choroidal neovascularisation secondary to punctate inner choroidopathy. Clin Exp Ophthalmol 36(3):292–294CrossRefPubMed Vossmerbaeumer U, Spandau UHM, Baltz SV, Wickenhaeuser A, Jonas JB (2008) Intravitreal bevacizumab for choroidal neovascularisation secondary to punctate inner choroidopathy. Clin Exp Ophthalmol 36(3):292–294CrossRefPubMed
24.
Zurück zum Zitat Weiss S, Winter R, Meyer MW (2012) Punctate inner choroidopathy—Improvement in vision after anti-VEGF and photodynamic therapy. An 18-month follow-up control. Ophthalmologe 109(2):149–154CrossRefPubMed Weiss S, Winter R, Meyer MW (2012) Punctate inner choroidopathy—Improvement in vision after anti-VEGF and photodynamic therapy. An 18-month follow-up control. Ophthalmologe 109(2):149–154CrossRefPubMed
25.
Zurück zum Zitat Chan W, Lai TYY, Liu DTL, Lam DSC (2007) Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 143(6):977–983CrossRefPubMed Chan W, Lai TYY, Liu DTL, Lam DSC (2007) Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 143(6):977–983CrossRefPubMed
26.
Zurück zum Zitat Menezo V, Cuthbertson F, Downes SM (2010) Positive response to intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to punctate inner choroidopathy. Retina 30(9):1400–1404CrossRefPubMed Menezo V, Cuthbertson F, Downes SM (2010) Positive response to intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to punctate inner choroidopathy. Retina 30(9):1400–1404CrossRefPubMed
27.
Zurück zum Zitat Mansour AM, Mackensen F, Arevalo JF, Ziemssen F, Mahendradas P, Mehio-Sibai A, Hrisomalos N, Lai TY, Dodwell D, Chan WM, Ness T, Banker AS, Pai SA, Berrocal MH, Tohme R, Heiligenhaus A, Bashshur ZF, Khairallah M, Salem KM, Hrisomalos FN, Wood MH, Heriot W, Adan A, Kumar A, Lim L, Hall A, Becker M (2008) Intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol 146(3):410–416CrossRefPubMed Mansour AM, Mackensen F, Arevalo JF, Ziemssen F, Mahendradas P, Mehio-Sibai A, Hrisomalos N, Lai TY, Dodwell D, Chan WM, Ness T, Banker AS, Pai SA, Berrocal MH, Tohme R, Heiligenhaus A, Bashshur ZF, Khairallah M, Salem KM, Hrisomalos FN, Wood MH, Heriot W, Adan A, Kumar A, Lim L, Hall A, Becker M (2008) Intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol 146(3):410–416CrossRefPubMed
28.
Zurück zum Zitat Arevalo JF, Adan A, Berrocal MH, Espinoza JV, Maia M, Wu L, Roca JA, Quiroz-Mercado H, Ruiz-Moreno JM, Serrano MA (2011) Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months. Retina 31(2):353–363CrossRefPubMed Arevalo JF, Adan A, Berrocal MH, Espinoza JV, Maia M, Wu L, Roca JA, Quiroz-Mercado H, Ruiz-Moreno JM, Serrano MA (2011) Intravitreal bevacizumab for inflammatory choroidal neovascularization: results from the Pan-American Collaborative Retina Study Group at 24 months. Retina 31(2):353–363CrossRefPubMed
29.
Zurück zum Zitat Winterhalter S, Joussen AM, Pleyer U, Stübiger N (2012) Inflammatory choroidal neovascularisations. Klin Monatsbl Augenheilkde 229(9):897–904CrossRef Winterhalter S, Joussen AM, Pleyer U, Stübiger N (2012) Inflammatory choroidal neovascularisations. Klin Monatsbl Augenheilkde 229(9):897–904CrossRef
30.
Zurück zum Zitat Pachydaki SI, Jakobiec A, Bhat P, Sobrin L, Michaud NA, Seshan SV, D’Amico DJ (2012) Surgical management and ultrastructural study of choroidal neovascularization in punctate inner choroidopathy. J Ophthal Inflamm Infect 2:29–37CrossRef Pachydaki SI, Jakobiec A, Bhat P, Sobrin L, Michaud NA, Seshan SV, D’Amico DJ (2012) Surgical management and ultrastructural study of choroidal neovascularization in punctate inner choroidopathy. J Ophthal Inflamm Infect 2:29–37CrossRef
31.
Zurück zum Zitat Neri P, Manoni M, Fortuna C, Lettieri M, Mariotti C, Giovannini A (2010) Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunesuppressants: interventional case series. Int Ophthalmol 30:583–590CrossRefPubMed Neri P, Manoni M, Fortuna C, Lettieri M, Mariotti C, Giovannini A (2010) Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunesuppressants: interventional case series. Int Ophthalmol 30:583–590CrossRefPubMed
32.
Zurück zum Zitat Spaide RF (1999) Choroidal neovascularization in younger patients. Curr Opin Ophthalmol 10(3):177–181CrossRefPubMed Spaide RF (1999) Choroidal neovascularization in younger patients. Curr Opin Ophthalmol 10(3):177–181CrossRefPubMed
Metadaten
Titel
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy
verfasst von
T. Barth
F. Zeman
H. Helbig
M.-A. Gamulescu
Publikationsdatum
19.04.2017
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 3/2018
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-017-0536-0

Weitere Artikel der Ausgabe 3/2018

International Ophthalmology 3/2018 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Open Access 22.02.2024 | Peeling | Originalien

Selektive Vitalfarbstoffe in der Makulachirurgie

Erhöhen sie die Wahrscheinlichkeit der intraoperativen ILM-Identifizierung auch bei einem erfahrenen Operateur?

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.